Skip to main content
Article thumbnail
Location of Repository

Generation of cell lines to complement Adenovirus vectors using recombination-mediated cassette exchange

By S. J. (Susan J.) Morris, Daniel C. Farley and Keith Leppard


Background\ud Adenovirus serotype 5 (Ad5) has many favourable characteristics for development as a gene therapy vector. However, the utility of current Ad5 vectors is limited by transient transgene expression, toxicity and immunogenicity. The most promising form of vector is the high capacity type, which is deleted for all viral genes. However, these vectors can only be produced to relatively low titres and with the aid of helper virus. Therefore a continuing challenge is the generation of more effective Ad5 vectors that can still be grown to high titres. Our approach is to generate complementing cell lines to support the growth of Ad5 vectors with novel late gene deficiencies.\ud \ud Results\ud We have used LoxP/Cre recombination mediated cassette exchange (RMCE) to generate cell lines expressing Ad5 proteins encoded by the L4 region of the genome, the products of which play a pivotal role in the expression of Ad5 structural proteins. A panel of LoxP parent 293 cell lines was generated, each containing a GFP expression cassette under the control of a tetracycline-regulated promoter inserted at a random genome location; the cassette also contained a LoxP site between the promoter and GFP sequence. Clones displayed a variety of patterns of regulation, stability and level of GFP expression. Clone A1 was identified as a suitable parent for creation of inducible cell lines because of the tight inducibility and stability of its GFP expression. Using LoxP-targeted, Cre recombinase-mediated insertion of an L4 cassette to displace GFP from the regulated promoter in this parent clone, cell line A1-L4 was generated. This cell line expressed L4 100K, 22K and 33K proteins at levels sufficient to complement L4-33K mutant and L4-deleted viruses.\ud \ud Conclusions\ud RMCE provides a method for rapid generation of Ad5 complementing cell lines from a pre-selected parental cell line, chosen for its desirable transgene expression characteristics. Parent cell lines can be selected for high or low gene expression, and for tight regulation, allowing viral protein expression to mirror that found during infection. Cell lines derived from a single parent will allow the growth of different vectors to be assessed without the complication of varying complementing protein expression

Topics: QH426, QR355
Publisher: BMC Biotechnology
Year: 2010
OAI identifier:

Suggested articles


  1. (2001). ACG: A ‘select and swap’ strategy for the isolation of clones with tightly regulated transgenes. doi
  2. (2004). Adenovirus vectors: Biology, design, and production. Adenoviruses: Model and Vectors in Virus-Host Interactions doi
  3. Adenoviruses: Molecular Biology. doi
  4. (1983). AJ: Monoclonal antibodies which recognize native and denatured forms of the adenovirus DNA-binding protein. Virology doi
  5. (2006). Akusjarvi G: L4-33K, an adenovirusencoded alternative RNA splicing factor. doi
  6. (2001). Amalfitano A: Adenovirus vectors with the 100K gene deleted and their potential for multiple gene therapy applications. doi
  7. (2000). Amalfitano A: Multiply deleted [E1, polymerase-, and pTP-] adenovirus vector persists despite deletion of the preterminal protein. doi
  8. (1999). Amalfitano A: Persistence of an E1(-), polymerase(-) adenovirus vector despite transduction of a neoantigen into immunecompetent mice. Hum Gene Ther doi
  9. (1996). Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy.
  10. (1999). Bouhassira EE: Site-specific chromosomal integration in mammalian cells: Highly efficient CRE recombinase-mediated cassette exchange. doi
  11. (1995). Bujard H: Efficacy of tetracycline-controlled gene-expression is influenced by cell-type - commentary. BioTechniques
  12. (1992). Bujard H: Tight control of gene-expression in mammalian cells by tetracycline-responsive promoters. doi
  13. (1984). Cajean-Feroldi C: Identification of Intranuclear Structures Containing the 72k DNA-Binding Protein of Human Adenovirus Type-5.
  14. (1977). Characterisics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol doi
  15. (2005). Chiou HC: Gene therapy progress and prospects: Recent progress in transgene and RNAi expression cassettes. Gene Ther doi
  16. (2007). Current advances and future challenges in adenoviral vector biology and targeting. Current Gene Therapy doi
  17. (2007). Dynamics and interplay of nuclear architecture, genome organization, and gene expression. doi
  18. (1996). Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli.
  19. (1997). et al: Long-term gene delivery into the livers of immunocompetent mice with E1/E4-defective adenoviruses.
  20. (2001). GD: A structural view of Cre-loxP site-specific recombination. Annu Rev Biophys Biomol Struct doi
  21. (2002). Gerwins P: How to make tetracycline-regulated transgene expression go on and off. Anal Biochem doi
  22. (1990). Gorman CM: Intervening Sequences Increase Efficiency doi
  23. (2004). Imperiale MJ: Biology of adenovirus and its use as a vector for gene therapy. Hum Gene Ther doi
  24. (1994). JM: Ablation of E2a in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse-liver. doi
  25. (1994). JM: Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. doi
  26. (1996). JM: Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis. Virology doi
  27. (1998). JS: Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted.
  28. (1997). Leboulch P: Transcriptional behavior of LCR enhancer elements integrated at the same chromosomal locus by recombinase-mediated cassette exchange. Blood
  29. (2004). Leppard KN: Activation of the early-late switch in adenovirus type 5 major late transcription unit expression by L4 gene products. doi
  30. (2010). Leppard KN: Adenovirus late phase infection is controlled by a novel L4 promoter. doi
  31. (2009). Leppard KN: Adenovirus serotype 5 L4-22K and L4-33K proteins have distinct functions in regulating late gene expression. doi
  32. (2003). Leppard KN: Nuclear matrix localization and SUMO-1 modification of adenovirus type 5 E1b 55K protein are controlled by doi
  33. (1994). MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity doi
  34. (1997). Phipps ML: Construction of adenovirus vectors through Cre-lox recombination.
  35. (1999). RD: The adenovirus type 5 E1b 55K and E4 Orf3 proteins associate in infected cells and affect ND10 components.
  36. (2009). Recombinant protein expression by targeting preselected chromosomal loci. doi
  37. (1995). Rescue, propagation, and partial-purification of a helper virus-dependent adenovirus vector. doi
  38. (2005). RJ: Regulation of translation by ribosome shunting through phosphotyrosine-dependent coupling of adenovirus protein 100k to viral mRNAs. doi
  39. (2004). RJ: Tethering of eIF4G to adenoviral mRNAs by viral 100k protein drives ribosome shunting. Genes & Development doi
  40. (1995). Schmauss C: The responsiveness of a tetracycline-sensitive expression system differs in different cell-lines. doi
  41. (1982). Sharp PA: Assembly of adenovirus major capsid protein is mediated by a nonvirion protein. Cell doi
  42. (2002). Shibui T: Construction of engineered CHO strains for high-level production of recombinant proteins. doi
  43. (1990). SJ: The adenovirus L4 100-kilodalton protein is necessary for efficient translation of viral late mRNA species.
  44. (2000). The cloned, humanized green fluorescent protein from Renilla reniformis is less cytotoxic than EGFP. Mol Biol Cell
  45. (2006). The L4 22-kilodalton protein plays a role in packaging of the adenovirus genome. doi
  46. (1996). Trapnell BC: Elimination of both E1 and E2a from adenovirus vectors further improves prospects for in vivo human gene therapy.
  47. (2001). Truncation of the human adenovirus type 5 L4 33 kDa protein: evidence for an essential role of the carboxy terminus in the viral replication cycle. Virology doi
  48. (1997). Yamamura KI: Targeted integration of DNA using mutant lox sites in embryonic stem cells. Nucleic Acids Res doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.